Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ALACT

Acticor Biotech (ALACT)

Acticor Biotech
Date:
Sort by:
 Showing the most relevant articles for your search:EU:ALACT
DateTimeSourceHeadlineSymbolCompany
06/03/202411:15AMGlobeNewswire Inc.Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergenciesEU:ALACTActicor Biotech
02/07/202411:00AMGlobeNewswire Inc.The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attackEU:ALACTActicor Biotech
11/07/20233:34AMGlobeNewswire Inc.Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in strokeEU:ALACTActicor Biotech
09/14/202311:15AMGlobeNewswire Inc.Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatment of strokeEU:ALACTActicor Biotech
 Showing the most relevant articles for your search:EU:ALACT